Aminoguanidine inhibits semicarbazide-sensitive amine oxidase activity: implications for advanced glycation and diabetic complications

Diabetologia

Volumn 40, Issue 11, 1997, Pages 1243-1250

  Yu, P H ^a   Zuo, D M ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

advanced glycation; Aminoguanidine; diabetes; formaldehyde; glycoxidation; methylamine; semicarbazide sensitive amine oxidase (SSAO); SSAO inhibitor; streptozotocin

Indexed keywords

AMINE OXIDASE (COPPER CONTAINING); AMINOGUANIDINE; ENZYME INHIBITOR; FORMALDEHYDE; GLYCOSYLATED HEMOGLOBIN; HYDRAZINE DERIVATIVE; LACTATE DEHYDROGENASE; METHYLAMINE; MOFEGILINE; STREPTOZOCIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC ANGIOPATHY; DIABETIC NEPHROPATHY; DRUG EFFECT; ENZYME INHIBITION; HUMAN; HUMAN TISSUE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; RAT; STREPTOZOCIN DIABETES; URINARY EXCRETION;

AMINE OXIDASE (COPPER-CONTAINING); ANIMALS; AORTA; DIABETES MELLITUS, EXPERIMENTAL; ENZYME INHIBITORS; FORMALDEHYDE; GLYCOSYLATION END PRODUCTS, ADVANCED; GUANIDINES; HUMANS; KIDNEY; L-LACTATE DEHYDROGENASE; METHYLAMINES; RATS; RATS, WISTAR; RIBONUCLEASES; TIME FACTORS; UMBILICAL ARTERIES;

EID: 0030785422     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s001250050816     Document Type: Article

References (57)

1. 1. M Brownlee A Cerami H Vlassara 1988 Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications N Engl J Med 318 1315 1321 3283558 1:STN:280:DyaL1c3gt1SksA%3D%3D Brownlee M, Cerami A, Vlassara H (1988) Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318:1315–1321
2. 2. M Brownlee 1992 Non-enzymatic glycosylation of macro-molecules: prospects of pharmacological modulation Diabetes 41 2 57 60 1526337 1:CAS:528:DyaK38XmsVCrtr0%3D Brownlee M (1992) Non-enzymatic glycosylation of macro-molecules: prospects of pharmacological modulation. Diabetes 41 [Suppl 2]: 57–60
3. 3. MX Fu KJ Knecht SR Thorpe JW Baynes 1992 Role of oxygen in cross linking and chemical modification of collagen by glucose Diabetes 41 2 42 48 1526335 1:CAS:528:DyaK38XmtlWntbg%3D Fu MX, Knecht KJ, Thorpe SR, Baynes JW (1992) Role of oxygen in cross linking and chemical modification of collagen by glucose. Diabetes 41[Suppl 2]: 42–48
4. 4. JW Baynes 1991 Role of oxidated stress in development of complications in diabetes Diabetes 40 405 412 2010041 10.2337/diabetes.40.4.405 1:CAS:528:DyaK3MXktVGqur8%3D Baynes JW (1991) Role of oxidated stress in development of complications in diabetes. Diabetes 40: 405–412
5. 5. JV Hunt MA Bottoms MJ Mitchinson 1993 Oxidative alteration in the experimental glycation model of diabetes mellitus are due to protein-glucose adduct oxidation Bio-chem J 291 529 535 1:CAS:528:DyaK3sXksVKks74%3D Hunt JV, Bottoms MA, Mitchinson MJ (1993) Oxidative alteration in the experimental glycation model of diabetes mellitus are due to protein-glucose adduct oxidation. Bio-chem J 291: 529–535
6. 6. JV Hunt CCT Smith SP Wolff 1990 Autooxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose Diabetes 39 1420 1424 2227114 10.2337/diabetes.39.11.1420 1:CAS:528:DyaK3MXhs1WrtLc%3D Hunt JV, Smith CCT, Wolff SP (1990) Autooxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose. Diabetes 39: 1420–1424
7. 7. VM Monnier RR Kohn A Cerami 1984 Accelerated age related browning of human collagen in diabetes mellitus Proc Natl Acad Sci USA 81 583 587 6582514 10.1073/pnas.81.2.583 1:CAS:528:DyaL2cXhtFyrurs%3D Monnier VM, Kohn RR, Cerami A (1984) Accelerated age related browning of human collagen in diabetes mellitus. Proc Natl Acad Sci USA 81: 583–587
8. 8. SK Lo K Janakidevi L Lai AB Malik 1993 Hydrogen peroxide-induced increase in endothelial adhesiveness is dependent on ICAM-1 activation Am J Physiol 264 L406 L412 7682787 1:CAS:528:DyaK3sXks1yqt7o%3D Lo SK, Janakidevi K, Lai L, Malik AB (1993) Hydrogen peroxide-induced increase in endothelial adhesiveness is dependent on ICAM-1 activation. Am J Physiol 264: L406-L412
9. 9. MIJ Uusitupa LK Niskanen O Sittonen E Voutilainen K Pyorala 1993 Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and nondiabetic subjects Diabetologia 36 1175 1184 8270133 10.1007/BF00401063 1:STN:280:DyaK2c%2FpsFSmtw%3D%3D Uusitupa MIJ, Niskanen LK, Sittonen O, Voutilainen E, Pyorala K (1993) Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and nondiabetic subjects. Diabetologia 36:1175–1184
10. 10. M Brownlee 1985 A Marble Microvascular disease and related abnormalities: Their relation to control of diabetes Lea & Febiger Philadelphia 185 216 Brownlee M (1985) Microvascular disease and related abnormalities: Their relation to control of diabetes. In: Marble A et al. (eds) Joslin’s diabetes mellitus. Lea & Febiger, Philadelphia pp 185–216
11. 11. CJ Mullarkey D Edelstein M Brownlee 1990 Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes Biochem Bio-phys Res Comm 173 932 939 10.1016/S0006-291X(05)80875-7 1:CAS:528:DyaK3MXlvFykuw%3D%3D Mullarkey CJ, Edelstein D, Brownlee M (1990) Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes. Biochem Bio-phys Res Comm 173: 932–939
12. 12. J Brett S Ogawa M Kirstein S Radoff H Vlassara D Stem 1990 Advanced glycosylation end products selectively attract monocytes to migrate across endothelial cell monolayers and induce activation and growth factor elaboration Circulation 82 3 92 92 Brett J, Ogawa S, Kirstein M, Radoff S, Vlassara H, Stem D (1990) Advanced glycosylation end products selectively attract monocytes to migrate across endothelial cell monolayers and induce activation and growth factor elaboration. Circulation 82[Suppl 3]: 92 (Abstract)
13. 13. H Vlassara Z Makita E Rayfield E Freidman A Cerami S Morgelo 1990 In vitro advanced glycation as a signal for monocyte migration in vessel wall: role in diabetes and aging Circulation 82 3 92 92 Vlassara H, Makita Z, Rayfield E, Freidman E, Cerami A, Morgelo S (1990) In vitro advanced glycation as a signal for monocyte migration in vessel wall: role in diabetes and aging. Circulation 82[Suppl 3]: 92 (Abstract)
14. 14. D Edelstein M Brownlee 1992 Mechanistic studies of advanced glycosylation end product inhibition by aminoguanidine Diabetes 41 26 29 1727735 10.2337/diabetes.41.1.26 1:CAS:528:DyaK38XltFejsA%3D%3D Edelstein D, Brownlee M (1992) Mechanistic studies of advanced glycosylation end product inhibition by aminoguanidine. Diabetes 41: 26–29
15. 15. T Soulis-Liparota M Cooper D Papazoglou B Clarke G Jerums 1991 Retardation by aminoguanidine of development of albuminuria, mesangial expansion and tissue fluorescence in streptozotocin induced diabetic rats Diabetes 40 1328 1335 1834497 10.2337/diabetes.40.10.1328 1:CAS:528:DyaK3MXlvFyhsr0%3D Soulis-Liparota T, Cooper M, Papazoglou D, Clarke B, Jerums G (1991) Retardation by aminoguanidine of development of albuminuria, mesangial expansion and tissue fluorescence in streptozotocin induced diabetic rats. Diabetes 40:1328–1335
16. 16. R Bucala Z Makita T Koschinsky A Cerami H Vlassara 1993 Lipid advanced glycation: pathway for lipid oxidation in vivo Proc Natl Acad Sci USA 90 6434 6438 8341651 10.1073/pnas.90.14.6434 1:CAS:528:DyaK3sXlsFOltrs%3D Bucala R, Makita Z, Koschinsky T, Cerami A, Vlassara H (1993) Lipid advanced glycation: pathway for lipid oxidation in vivo. Proc Natl Acad Sci USA 90: 6434–6438
17. 17. S Picard S Parathasarathy J Fruebis JL Witzum 1992 Aminoguanidine inhibits oxidative modification of low density lipoprotein and the subsequent increase in uptake by macrophage scavenger receptors Proc Natl Acad Sci USA 89 6876 6880 1495978 10.1073/pnas.89.15.6876 1:CAS:528:DyaK38XlsVehsrc%3D Picard S, Parathasarathy S, Fruebis J, Witzum JL (1992) Aminoguanidine inhibits oxidative modification of low density lipoprotein and the subsequent increase in uptake by macrophage scavenger receptors. Proc Natl Acad Sci USA 89: 6876–6880
18. 18. RE O’Brien S Panangiotopoulos MS Cooper G Jerums 1992 Anti-atherogenic effect of aminoguanidine, an inhibitor of advanced glycation Diabetes 4 1 16A 16A O’Brien RE, Panangiotopoulos S, Cooper MS, Jerums G (1992) Anti-atherogenic effect of aminoguanidine, an inhibitor of advanced glycation. Diabetes 4[Suppl 1] 16A (Abstract)
19. 19. M Itakura H Yoshikawa C Bannai 1992 Aminoguanidine decreases urinary albumin and high-molecular weight proteins in diabetic rats Life Sci 49 889 897 10.1016/0024-3205(91)90174-A Itakura M, Yoshikawa H, Bannai C et al. (1992) Aminoguanidine decreases urinary albumin and high-molecular weight proteins in diabetic rats. Life Sci 49: 889–897
20. 20. MSP Huijiberts BHR Wolffenbuttel FRL Crijns 1994 Aminoguanidine reduces regional albumin clearance but not urinary albumin excretion in streptozotocin-diabetic rats Diabetologia 37 10 14 10.1007/BF00428771 Huijiberts MSP, Wolffenbuttel BHR, Crijns FRL et al. (1994) Aminoguanidine reduces regional albumin clearance but not urinary albumin excretion in streptozotocin-diabetic rats. Diabetologia 37:10–14
21. 21. PH Yu 1990 Oxidative deamination of aliphatic amines by rat aorta semicarbazide-sensitive amine oxidase J Pharm Pharmacol 42 882 884 1983156 1:CAS:528:DyaK3MXitVShuw%3D%3D Yu PH (1990) Oxidative deamination of aliphatic amines by rat aorta semicarbazide-sensitive amine oxidase. J Pharm Pharmacol 42: 882–884
22. 22. PJ Boor MB Trent GA Lyles M Tao GAS Ansari 1992 Methylamine metabolism to formaldehyde by vascular semicarbazide-sensitive amine oxidase Toxicology 73 251 258 1631902 10.1016/0300-483X(92)90067-O 1:CAS:528:DyaK38XlsVGjsrk%3D Boor PJ, Trent MB, Lyles GA, Tao M, Ansari GAS (1992) Methylamine metabolism to formaldehyde by vascular semicarbazide-sensitive amine oxidase. Toxicology 73: 251–258
23. 23. CM McEwen DO Castell 1967 Abnormalities of serum monoamine oxidase in chronic liver disease J Lab Clin Med 70 36 47 6027096 1:CAS:528:DyaF2sXksFaisrs%3D McEwen CM Jr, Castell DO (1967) Abnormalities of serum monoamine oxidase in chronic liver disease. J Lab Clin Med 70: 36–47
24. 24. SE Nilsson N Tryding G Tufvesson 1968 Serum monoamine oxidase in diabetes mellitus and some other internal diseases Acta Med Scand 184 105 108 5703957 1:CAS:528:DyaF1MXpvFOj Nilsson SE, Tryding N, Tufvesson G (1968) Serum monoamine oxidase in diabetes mellitus and some other internal diseases. Acta Med Scand 184:105–108
25. 25. N Tryding SE Nilsson G Tufvesson 1969 Physiological and pathological influences on serum monoamine oxidase level Scan J Clin Lab Invest 23 79 84 10.3109/00365516909078089 1:CAS:528:DyaF1MXhtFeiuro%3D Tryding N, Nilsson SE, Tufvesson G et al. (1969) Physiological and pathological influences on serum monoamine oxidase level. Scan J Clin Lab Invest 23: 79–84
26. 26. F Boomsma FHM Derkx AH Meiracker van den AJM Veld MADH Schalekamp 1995 Plasma semicarbazide-sensitive amine oxidase activity is elevated in diabetes mellitus and correlates with glycosylated haemoglobin Clin Sci 88 675 679 7634751 1:STN:280:DyaK2MzmtFCntQ%3D%3D Boomsma F, Derkx FHM, van den Meiracker AH, Veld AJM, Schalekamp MADH (1995) Plasma semicarbazide-sensitive amine oxidase activity is elevated in diabetes mellitus and correlates with glycosylated haemoglobin. Clin Sci 88: 675–679
27. 27. BE Hayes DE Clarke 1990 Semicarbazide-sensitive amine oxidase activity in streptozotocin diabetic rats Res Comm Chem Pathol Pharmacol 69 71 83 1:CAS:528:DyaK3cXltlSjtLY%3D Hayes BE, Clarke DE (1990) Semicarbazide-sensitive amine oxidase activity in streptozotocin diabetic rats. Res Comm Chem Pathol Pharmacol 69: 71–83
28. 28. J Elliott AL Fowden BA Callingham DF Sharman M Silver 1991 Physiological and pathological influences on sheep blood plasma amine oxidase: effect of pregnancy and experimental alloxan-induced diabetes mellitus Res Vet Science 50 334 339 1:CAS:528:DyaK3MXltFajs7g%3D Elliott J, Fowden AL, Callingham BA, Sharman DF, Silver M (1991) Physiological and pathological influences on sheep blood plasma amine oxidase: effect of pregnancy and experimental alloxan-induced diabetes mellitus. Res Vet Science 50: 334–339
29. 29. PH Yu DM Zuo 1993 Methylamine, a potential endogenous toxin for vascular tissues: formation of formaldehyde via enzymatic deamination and the cytotoxic effects on endothelial cells Diabetes 42 594 603 8454111 10.2337/diabetes.42.4.594 1:CAS:528:DyaK3sXktVKhu7Y%3D Yu PH, Zuo DM (1993) Methylamine, a potential endogenous toxin for vascular tissues: formation of formaldehyde via enzymatic deamination and the cytotoxic effects on endothelial cells. Diabetes 42: 594–603
30. 30. PH Yu DM Zuo 1991 (E)-4-Fluoro-beta-fluoroethylene benzene butamine (MDL-72974A) as highly potent inhibitor for semicarbazide-sensitive amine oxidase from vascular tissues and serum of different species Biochem Pharmacol 43 307 312 10.1016/0006-2952(92)90293-R Yu PH, Zuo DM (1991) (E)-4-Fluoro-beta-fluoroethylene benzene butamine (MDL-72974A) as highly potent inhibitor for semicarbazide-sensitive amine oxidase from vascular tissues and serum of different species. Biochem Pharmacol 43: 307–312
31. 31. S Chouinard C Viau 1992 Reversibility of renal tubular dysfunction in streptozotocin-induced diabetes in the rat Can J Physiol Pharmacol 70 977 982 1451036 1:CAS:528:DyaK38XmtlWnu74%3D Chouinard S, Viau C (1992) Reversibility of renal tubular dysfunction in streptozotocin-induced diabetes in the rat. Can J Physiol Pharmacol 70: 977–982
32. 32. SM Jane D Mu D Wemmer 1990 A new redox cofactor in eukaryotic enzymes: 6-hydroxydopa at the active site of bovine serum amine oxidase Science 248 981 987 10.1126/science.2111581 Jane SM, Mu D, Wemmer D et al. (1990) A new redox cofactor in eukaryotic enzymes: 6-hydroxydopa at the active site of bovine serum amine oxidase. Science 248: 981–987
33. 33. SM Jane JP Klinman 1991 An investigation of bovine serum amine oxidase active site stoichiometry: evidence for an aminotransferase mechanism involving two carbonyl cofactors per enzyme dimer Am Chem Soc 30 4599 4605 Jane SM, Klinman JP (1991) An investigation of bovine serum amine oxidase active site stoichiometry: evidence for an aminotransferase mechanism involving two carbonyl cofactors per enzyme dimer. Am Chem Soc 30: 4599–4605
34. 34. K Nicholis TE Mandel 1989 Advanced glycosylation end-products in experimental murine diabetic nephropathy: effect of islet isografting and of aminoguanidine Lab Invest 60 486 491 Nicholis K, Mandel TE (1989) Advanced glycosylation end-products in experimental murine diabetic nephropathy: effect of islet isografting and of aminoguanidine. Lab Invest 60: 486–491
35. 35. JA Corbett RG Tilton K Chang 1992 Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction Diabetes 41 552 556 1376704 10.2337/diabetes.41.4.552 1:CAS:528:DyaK38XisVyhsr4%3D Corbett JA, Tilton RG, Chang K et al. (1992) Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes 41: 552–556
36. 36. RG Tilton K Chang KS Hason 1993 Prevention of diabetic vascular dysfunction by guanidines; inhibition of nitric oxide synthase versus advanced glycation end-product formation Diabetes 42 221 232 7678825 10.2337/diabetes.42.2.221 1:CAS:528:DyaK3sXhtFKmsb0%3D Tilton RG, Chang K, Hason KS et al. (1993) Prevention of diabetic vascular dysfunction by guanidines; inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes 42: 221–232
37. 37. H Tamura K Horiike H Fukura T Watanabe 1989 Kinetic studies on the inhibition mechanism of diamine oxidase from porcine kidney by aminoguanidine J Biochem (Tokyo) 105 299 306 1:CAS:528:DyaL1MXhtlWitLY%3D Tamura H, Horiike K, Fukura H, Watanabe T (1989) Kinetic studies on the inhibition mechanism of diamine oxidase from porcine kidney by aminoguanidine. J Biochem (Tokyo) 105: 299–306
38. 38. N Seiler 1995 Polyamine oxidase, properties and functions Prog Brain Res 106 333 344 8584670 10.1016/S0079-6123(08)61229-7 1:CAS:528:DyaK28XpsF2lug%3D%3D Seiler N (1995) Polyamine oxidase, properties and functions. Prog Brain Res 106: 333–344
39. 39. BH Mathison SE Murphy R Shank 1994 Hydralazine and other hydrazine derivatives and the formation of DNA adducts Toxicol Appl Pharmacol 127 91 98 8048059 10.1006/taap.1994.1143 1:CAS:528:DyaK2cXlslSitr4%3D Mathison BH, Murphy SE, Shank R (1994) Hydralazine and other hydrazine derivatives and the formation of DNA adducts. Toxicol Appl Pharmacol 127: 91–98
40. 40. WS Bosan RC Shank JD MacEven CL Gaworske PM Newberne 1987 Methylation of DNA guanine during the course of induction of liver cancer in hamsters by hydrazine or dimethylnitrosamine Carcinogenesis 8 439 444 3815739 10.1093/carcin/8.3.439 1:CAS:528:DyaL2sXlslSgtLw%3D Bosan WS, Shank RC, MacEven JD, Gaworske CL, Newberne PM (1987) Methylation of DNA guanine during the course of induction of liver cancer in hamsters by hydrazine or dimethylnitrosamine. Carcinogenesis 8: 439–444
41. 41. A Helander O Tottmar 1987 Metabolism of biogenic aldehydes in isolated human blood cells, platelets and in plasma Biochem Pharmacol 36 1077 1082 2436624 10.1016/0006-2952(87)90417-5 1:CAS:528:DyaL2sXitVyhtrk%3D Helander A, Tottmar O (1987) Metabolism of biogenic aldehydes in isolated human blood cells, platelets and in plasma. Biochem Pharmacol 36: 1077–1082
42. 42. Y Sato N Hotta N Sakamonto S Matsuoka N Ohishin IK Yagi 1979 Lipid peroxide levels in plasma of diabetic patients Biochem Med 21 104 107 454385 10.1016/0006-2944(79)90061-9 1:CAS:528:DyaE1MXktFOrtbs%3D Sato Y, Hotta N, Sakamonto N, Matsuoka S, Ohishin N, Yagi IK (1979) Lipid peroxide levels in plasma of diabetic patients. Biochem Med 21: 104–107
43. 43. PE Jennings AF Jones CM Florkouski J Lunic AH Barnett 1987 Increased diene conjugates in diabetic subjects with microangiopathy Diabet Med 4 452 456 2959437 1:STN:280:DyaL1c%2FivVCitA%3D%3D 10.1111/j.1464-5491.1987.tb00908.x Jennings PE, Jones AF, Florkouski CM, Lunic J, Barnett AH (1987) Increased diene conjugates in diabetic subjects with microangiopathy. Diabet Med 4: 452–456
44. 44. T Ohkuwa Y Sato M Naoi 1995 Hydroxyl radical formation in diabetic rats induced by streptozotocin Life Sci 56 1789 1798 7739353 10.1016/0024-3205(95)00150-5 1:CAS:528:DyaK2MXltFaksLg%3D Ohkuwa T, Sato Y, Naoi M (1995) Hydroxyl radical formation in diabetic rats induced by streptozotocin. Life Sci 56: 1789–1798
45. 45. JMC Gutteridge 1994 Hydroxyl radicals, iron, oxidative stress and neurodegeneration Ann N Y Acad Sci 738 201 213 7832429 1:CAS:528:DyaK28XjvV2ksrw%3D 10.1111/j.1749-6632.1994.tb21805.x Gutteridge JMC (1994) Hydroxyl radicals, iron, oxidative stress and neurodegeneration. Ann N Y Acad Sci 738: 201–213
46. 46. GA Lyles I Singh 1985 Vascular smooth muscle cells: a major source of the semicarbazide-sensitive amine oxidase of the rat aorta J Pharm Pharmacol 37 637 643 2867184 1:CAS:528:DyaL2MXlsFOqtrc%3D Lyles GA, Singh I (1985) Vascular smooth muscle cells: a major source of the semicarbazide-sensitive amine oxidase of the rat aorta. J Pharm Pharmacol 37: 637–643
47. 47. M Wibo AT Duong T Godfraind 1980 Subcellular location of semicarbazide-sensitive amine oxidase in rat aorta Eur J Biochem 112 87 94 7449765 10.1111/j.1432-1033.1980.tb04990.x 1:CAS:528:DyaL3cXmtlGrtr4%3D Wibo M, Duong AT, Godfraind T (1980) Subcellular location of semicarbazide-sensitive amine oxidase in rat aorta. Eur J Biochem 112: 87–94
48. 48. GA Lyles KH Bertie 1987 Properties of a semicarbazide-sensitive amine oxidase in rat articular cartilage Pharmacol Toxicol 1 33 33 Lyles GA, Bertie KH (1987) Properties of a semicarbazide-sensitive amine oxidase in rat articular cartilage. Pharmacol Toxicol [Suppl] 1: 33
49. 49. DM Zuo PH Yu 1993 Semicarbazide-sensitive amine oxidase and monoamine oxidase in rat brain microvessels, meninges, retina and eye sciera Brain Research Bull 33 307 311 10.1016/0361-9230(94)90198-8 Zuo, DM, Yu, PH (1993) Semicarbazide-sensitive amine oxidase and monoamine oxidase in rat brain microvessels, meninges, retina and eye sciera. Brain Research Bull 33: 307–311
50. 50. GA Lyles J Chalmers 1992 The metabolism of aminoacetone to methylglyoxal by semicarbazide-sensitive amine oxidase in human umbilical artery Biochem Pharmacol 31 1417 1424 10.1016/0006-2952(82)90037-5 Lyles GA, Chalmers J (1992) The metabolism of aminoacetone to methylglyoxal by semicarbazide-sensitive amine oxidase in human umbilical artery. Biochem Pharmacol 31: 1417–1424
51. 51. PH Yu DM Zuo 1995 Formaldehyde produced endogenously via deamination of methylamine; a potential risk factor for initiation of endothelial injury Atherosclerosis 120 189 197 10.1016/0021-9150(95)05701-3 Yu PH, Zuo DM (1995) Formaldehyde produced endogenously via deamination of methylamine; a potential risk factor for initiation of endothelial injury. Atherosclerosis 120: 189–197
52. 52. R Kapeller-Adler K Toda 1932 Über das Vorkommen von Monomethylamine im Harn Biochem Zeischrift 248 403 425 1:CAS:528:DyaA38XksVyltw%3D%3D Kapeller-Adler R, Toda K (1932) Über das Vorkommen von Monomethylamine im Harn. Biochem Zeischrift 248: 403–425
53. 53. AC McLellan SA Phillips PJ Thornalley 1992 The assay of methylglyoxal in biological systems by derivatization with 1,2-diamino-4,5-dimethoxybenzene Anal Biochem 206 17 23 1456430 10.1016/S0003-2697(05)80005-3 1:CAS:528:DyaK38XlvVOmsbg%3D McLellan AC, Phillips SA, Thornalley PJ (1992) The assay of methylglyoxal in biological systems by derivatization with 1,2-diamino-4,5-dimethoxybenzene. Anal Biochem 206: 17–23
54. 54. TWC Lo ME Westwood AC McLellan T Seiwood PJ Thornalley 1994 Binding and modification of proteins by methylglyoxal and physiological conditions J Biol Chem 269 32299 32305 7798230 1:CAS:528:DyaK2cXmvFGnur0%3D Lo TWC, Westwood ME, McLellan AC Seiwood T, Thornalley PJ (1994) Binding and modification of proteins by methylglyoxal and physiological conditions. J Biol Chem 269: 32299–32305
55. 55. PJ Thornalley 1990 The glyoxalase system: new developments towards functional characterization of a metabolic pathway fundamental to biological life Biochem J 269 1 11 2198020 1:CAS:528:DyaK3cXkslens74%3D Thornalley PJ (1990) The glyoxalase system: new developments towards functional characterization of a metabolic pathway fundamental to biological life. Biochem J 269: 1–11
56. 56. M Brownlee H Vlassara P Kooney P Ulrich A Cerai 1986 Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking Science 232 1629 1632 3487117 10.1126/science.3487117 1:CAS:528:DyaL28Xkslantr8%3D Brownlee M, Vlassara H, Kooney P, Ulrich P, Cerai A (1986) Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science 232: 1629–1632
57. 57. TWC Lo T Selwood PJ Thornalley 1994 The reaction of methylglyoxal with aminoguanidine under physiological conditions and prevention of methylglyoxal binding to plasma proteins Biochem Pharmacol 48 1865 1870 7986197 10.1016/0006-2952(94)90584-3 1:CAS:528:DyaK2MXisVGnsrw%3D Lo TWC, Selwood T, Thornalley PJ (1994) The reaction of methylglyoxal with aminoguanidine under physiological conditions and prevention of methylglyoxal binding to plasma proteins. Biochem Pharmacol 48: 1865–1870